Stonepine Capital Management LLC 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:34 pm Sale |
2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management LLC | 5,937,000 4.300% |
-5,258,189 (-46.97%) |
Filing |
| 2023-02-13 10:57 am Purchase |
2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management LLC | 11,195,189 8.200% |
4,704,090 (+72.47%) |
Filing |
| 2022-01-13 6:13 pm Purchase |
2022-01-07 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management LLC | 6,491,099 5.200% |
6,491,099 (New Position) |
Filing |